Do We Still Need a BCLC‐Intermediate Stage for Hepatocellular Carcinoma‐Management?

Authors

Institutions

Publication Details

Journal
Liver International
Published
2026-01-16
DOI
https://doi.org/10.1111/liv.70517
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Do We Still Need a BCLC‐Intermediate Stage for Hepatocellular Carcinoma‐Management?

Markus Peck‐Radosavljevic
Liver International
Hepatocellular Carcinoma Treatment and Prognosis
article

Do We Still Need a BCLC‐Intermediate Stage for Hepatocellular Carcinoma‐Management?

Markus Peck‐Radosavljevic
article en

Abstract

No abstract available for this paper.
Liver InternationalVol. 46(2)
Klinikum Klagenfurt (AT)
Good health and well-being
Openalex Percentile: Top 85%
Hepatocellular Carcinoma Treatment and Prognosis
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.